U.S. Markets open in 2 hrs 33 mins

Ultragenyx: 4Q Earnings Snapshot

NOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $93.8 million in its fourth quarter.

On a per-share basis, the Novato, California-based company said it had a loss of $1.62. Losses, adjusted for non-recurring gains, were $1.64 per share.

The results did not meet Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.61 per share.

The biotechnology company posted revenue of $35.6 million in the period, surpassing Street forecasts. Eight analysts surveyed by Zacks expected $32.3 million.

For the year, the company reported that its loss widened to $402.7 million, or $7.12 per share. Revenue was reported as $103.7 million.

Ultragenyx shares have risen 47% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $62.90, a rise of 15% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RARE at https://www.zacks.com/ap/RARE